ARTICLE | Distillery Therapeutics
Enhancing SLC12A5 activity to treat refractory neonatal seizures
December 3, 2021 5:44 PM UTC
DISEASE CATEGORY: Neurology
INDICATION: Seizures...
BCIQ Company Profiles
DISEASE CATEGORY: Neurology
INDICATION: Seizures...
BCIQ Company Profiles
BCIQ Company Profiles